Form 4 for TDOC Teladoc Health, Inc.
Accepted 2026-03-03 00:00:00 ET · period of report 2026-02-27 · accession 0001714468-26-000004 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-03-03 | 2026-02-27 | TDOC | Catapano Joseph Ronald | CAO | M - OptEx | — | +3,488 | 10.2K | +52% | — |
| D | 2026-03-03 | 2026-03-02 | TDOC | Catapano Joseph Ronald | CAO | S - Sale+OE | $5.12 | -1,333 | 8,841 | -13% | -$6,825 |
| DM | 2026-03-03 | 2026-02-27 | TDOC | Catapano Joseph Ronald | CAO | M - OptEx | $0.00 | -3,488 | 6,667 | -34% | $0 |
| DM | 2026-03-03 | 2026-02-27+ | TDOC | Catapano Joseph Ronald | CAO | A - Grant | $0.00 | +15.5K | 15.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-02-27 | M | A | 3,333 | — | 10,019 | D | — | — | (F1) Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. |
| 2 | Common | Common Stock | 2026-03-02 | S | D | 1,333 | $5.12 | 8,841 | D | — | — | (F3) Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards. |
| 3 | Common | Common Stock | 2026-02-27 | M | A | 155 | — | 10,174 | D | — | — | (F2) Performance stock units convert to shares of TDOC common stock on a one-for-one basis. |
| 4 | Derivative | Performance Stock Units | 2026-02-27 | M | D | 155 | $0.00 | 310 | D | — · — to — | 155 Common Stock | (F2) Performance stock units convert to shares of TDOC common stock on a one-for-one basis. (F7) On March 1, 2026, the reporting person earned 465 performance stock units, vesting one-third on March 1, 2026, with the remainder vesting in eight substantially equal quarterly installments thereafter. |
| 5 | Derivative | Performance Stock Units | 2026-02-27 | A | A | 465 | $0.00 | 465 | D | — · — to — | 465 Common Stock | (F6) Performance award amount determined based on metrics in respect of the issuer's 2025 financial results. (F5) Each performance stock unit represents a contingent right to receive one share of TDOC common stock. |
| 6 | Derivative | Restricted Stock Units | 2026-02-27 | M | D | 3,333 | $0.00 | 6,667 | D | — · — to — | 3,333 Common Stock | (F1) Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. (F4) On March 1, 2025, the reporting person was granted 10,000 restricted stock units, vesting one-third on March 1, 2026, with the remainder vesting in eight substantially equal quarterly installments thereafter. |
| 7 | Derivative | Restricted Stock Units | 2026-03-01 | A | A | 15,000 | $0.00 | 15,000 | D | — · — to — | 15,000 Common Stock | (F8) Each restricted stock unit represents a contingent right to receive one share of TDOC common stock. (F9) One-third of the restricted stock units vest on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. |